Prevalence of atrial fibrillation and related factors in hospitalized old patients: ESFINGE study

被引:42
作者
Lopez Soto, Alfonso [1 ]
Formiga, Francesc
Bosch, Xavier [1 ,2 ]
Garcia Alegria, Javier [3 ]
机构
[1] Univ Barcelona, Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Serv Med Interna,Inst Clin Med & Dermatol, Barcelona, Spain
[2] Hosp Llobregat, Inst Invest Bellvitge IDIBELL, Med Interna Serv, Hosp Univ Bellvitge, Barcelona, Spain
[3] Hosp Costa del Sol, Med Interna Serv, Malaga, Spain
来源
MEDICINA CLINICA | 2012年 / 138卷 / 06期
关键词
Atrial fibrillation; Elderly; Heart failure; Antiarrhythmic drugs; ELDERLY-PATIENTS; RISK-FACTORS; ANTITHROMBOTIC THERAPY; ORAL ANTICOAGULATION; RANDOMIZED-TRIALS; STROKE PREVENTION; EUROPEAN-SOCIETY; TASK-FORCE; POPULATION; MANAGEMENT;
D O I
10.1016/j.medcli.2011.05.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: Atrial fibrillation (AF) is the commonest rhythm abnormality and it increases with ageing. The main objective of this study was to assess the prevalence of AF in hospitalized old patients as well as its characteristics and related clinical and therapeutic factors. Patients and methods: Prospective, multicenter, observational study in patients aged >= 70 years with AF, who had been hospitalized in Internal Medicine or Geriatrics wards. All variables studied were obtained from the patients' clinical records. Results: Out of 3,319 evaluable patients, 922 had an AF, which represents a prevalence of 31.3% (Cl 95%; 29.7-32.9). The mean age was 82 years (6.1; 69.9-101.8) and 57% were women. 88.7% of patients (818 p) had an AF before admission. AF was long-standing persistent or permanent in 728 cases (89.1%) and it was the first episode (paroxysmal or persistent) in 51 patients (6.2%). There was a clear etiology of AF in only 4.1% cases. Congestive heart failure was the commonest reason for hospitalization in our patients. Regarding the cardiovascular risk factors, 80.3% patients were hypertensive, 36.4% had dyslipemia, 38.2% had diabetes and 5% were active smokers. Associated diseases included renal insufficiency (38.1%) and chronic obstructive pulmonary disease (38.2%); in addition, 188 patients (20.4%) had suffered from cerebrovascular accidents. Finally, 67.4% patients had received antiarrhythmic drugs for their FA. Although 86.1% had received thromboembolic prevention therapy, only 54.1% were under oral anticoagulation. Finally, 6.9% patients had antiarrhythmic drugs-related side effects. Conclusions: Over one third of hospitalized patients older than 70 years have AF, which is generally relapsing and permanent. Heart failure is the commonest reason for hospitalization in these patients and about 40% have an asociated disease. (C) 2011 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:231 / 237
页数:7
相关论文
共 30 条
[1]   Use and clinical implications of anticoagulation maintenance after a successful cardioversion [J].
Alegret, Josep M. ;
Vinolas, Xavier ;
Villacastin, Julian ;
Martinez, Juan G. ;
Pachon, Nicolas ;
Crespo, Francisco .
MEDICINA CLINICA, 2011, 137 (01) :14-16
[2]   Management of the older person with atrial fibrillation [J].
Aronow, WS .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2002, 57 (06) :M352-M363
[3]   INDEPENDENT RISK-FACTORS FOR ATRIAL-FIBRILLATION IN A POPULATION-BASED COHORT - THE FRAMINGHAM HEART-STUDY [J].
BENJAMIN, EJ ;
LEVY, D ;
VAZIRI, SM ;
DAGOSTINO, RB ;
BELANGER, AJ ;
WOLF, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (11) :840-844
[4]   Use and effectiveness of warfarin in medicare beneficiaries with atrial fibrillation [J].
Birman-Deych, E ;
Radford, MJ ;
Nilasena, DS ;
Gage, BF .
STROKE, 2006, 37 (04) :1070-1074
[5]  
Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]
[6]   Prevalence of atrial fibrillation in the Spanish population aged 60 years or more.: The PREV-ICTUS study [J].
Cea-Calvo, Luis ;
Redon, Josep ;
Lozano, Jose V. ;
Fernandez-Perez, Cristina ;
Marti-Canales, Juan C. ;
Llisterri, Jose L. ;
Gonzalez-Esteban, Jorge ;
Aznar, Jose .
REVISTA ESPANOLA DE CARDIOLOGIA, 2007, 60 (06) :616-624
[7]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[8]   Antithrombotic therapy for the treatment of atrial fibrillation in the elderly [J].
Fang, Margaret C. .
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2009, 25 (01) :19-23
[9]   ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society [J].
Fuster, Valentin ;
Ryden, Lars E. ;
Cannom, David S. ;
Crijns, Harry J. ;
Curtis, Anne B. ;
Ellenbogen, Kenneth A. ;
Halperin, Jonathan L. ;
Le Heuzey, Jean-Yves ;
Kay, G. Neal ;
Lowe, James E. ;
Olsson, S. Bertil ;
Prystowsky, Eric N. ;
Tamargo, Juan Luis ;
Wann, Samuel .
CIRCULATION, 2006, 114 (07) :E257-E354
[10]  
García-Acuña JM, 2002, REV ESP CARDIOL, V55, P943